I. Kudaba: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Mok, Tony S K, Wu, Yi-Long, Kudaba, Iveta, Kowalski, Dariusz M, Cho, Byoung Chul, Turna, Hande Z, Castro, Gilberto, Srimuninnimit, Vichien, Laktionov, Konstantin K, Bondarenko, Igor, Kubota, Karou, Lu

Journal:

Lancet (London, England)

Year:

2019

Language:

english

File:

PDF, 1.18 MB

english, 2019

2

LBA-002Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study

Tabernero, J, Van Cutsem, E, Bang, Y, Fuchs, C, Wyrwicz, L, Lee, K, Kudaba, I, Garrido, M, Chung, H, Castro Salguero, H, Mansoor, W, Braghiroli, M, Goekkurt, E, Chao, J, Wainberg, Z, Kher, U, Shah, S,

Journal:

Annals of Oncology

Year:

2019

Language:

english

File:

PDF, 111 KB

english, 2019

3

The Utility of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography in the Investigation of Patients with Disseminated Carcinoma of Unknown Primary Origin

Clare L. Scott, Iveta Kudaba, Josephine M. Stewart, Rodney J. Hicks, Danny Rischin

Journal:

Molecular Imaging and Biology

Year:

2005

Language:

english

File:

PDF, 256 KB

english, 2005

4

PP-8-21 Response to neoadjuvant chemotheraphy in locally advanced breast cancer

G. Purkalne, I. Kudaba

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 177 KB

english, 1996

5

Absence of pharmacokinetic drug–drug interaction of pertuzumab with trastuzumab and docetaxel

Cortés, Javier, Swain, Sandra M., Kudaba, Iveta, Hauschild, Maik, Patel, Taral, Grincuka, Elza, Masuda, Norikazu, McNally, Virginia, Ross, Graham, Brewster, Mike, Marier, Jean-François, Trinh, My My,

Journal:

Anti-Cancer Drugs

Year:

2013

Language:

english

File:

PDF, 517 KB

english, 2013

6

Renal Cell Carcinoma – How Can We Predict its Outcomes in Clinical Practice?

Vaivode, Ieva, Lietuvietis, Vilnis, Hegmane, Alinta, Kudaba, Iveta

Journal:

Acta Chirurgica Latviensis

Year:

2013

Language:

english

File:

PDF, 104 KB

english, 2013

7

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial

Markóczy, Zsolt, Sárosi, Veronika, Kudaba, Iveta, Gálffy, Gabriella, Turay, Ülkü Yilmaz, Demirkazik, Ahmet, Purkalne, Gunta, Somfay, Attila, Pápai-Székely, Zsolt, Rásó, Erzsébet, Ostoros, Gyula

Journal:

Year:

2018

Language:

english

File:

PDF, 587 KB

english, 2018

8

PS1 Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS ≥1%

Lopes, G., Wu, Y., Kudaba, I., Kowalski, D., Cho, B., Turna, H., De Castro, G., Srimuninnimit, V., Laktionov, K., Bondarenko, I., Kubota, K., Lubiniecki, G., Zhang, J., Kush, D., Mok, T.

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 157 KB

english, 2018

9

102OFinal analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Mok, T S K, Wu, Y-L, Kudaba, I, Kowalski, D M, Cho, B C, Turna, H Z, de Castro, G, Srimuninnimit, V, Laktionov, K K, Bondarenko, I, Kubota, K, Caglevic, C, Karaszewska, B, Dang, T, Yin, L, Penrod, J,

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 112 KB

2019

10

125OPembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study

Chung, H C, Bang, Y-J, Tabernero, J, Van Cutsem, E, Fuchs, C S, Wyrwicz, L, Lee, K-W, Kudaba, I, Garrido, M, Castro, H, Mansoor, W, Braghiroli, M I, Goekkurt, E, Chao, J, Wainberg, Z A, Kher, U, Shah,

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 101 KB

2019

11

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

Shitara, Kohei, Van Cutsem, Eric, Bang, Yung-Jue, Fuchs, Charles, Wyrwicz, Lucjan, Lee, Keun-Wook, Kudaba, Iveta, Garrido, Marcelo, Chung, Hyun Cheol, Lee, Jeeyun, Castro, Hugo Raul, Mansoor, Wasat, B

Journal:

Year:

2020

File:

PDF, 487 KB

2020

12

Pharmacokinetics (PK) of Pertuzumab (P) With Trastuzumab (T) and Docetaxel (D) in HER2-Positive First-Line Metastatic Breast Cancer (MBC): Results From the Phase III Trial Cleopatra

Cortes, J., Swain, S., Kudaba, I., Hauschild, M., Patel, T., Grincuka, E., Masuda, N., McNally, V., Visich, J., Baselga, J.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 90 KB

2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски